Search Results - Zhiliang Weng

Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial by Limin Liao, Limin Liao, Limin Liao, Qinggang Liu, Qinggang Liu, Qinggang Liu, Huiling Cong, Huiling Cong, Zhihui Xu, Enhui Li, Zhiliang Weng, Haihong Jiang, Ben Liu, Xiao Huang, Shujie Xia, Wei Wen, Juan Wu, Juan Wu, Guowei Shi, Yang Wang, Peijun Li, Yang Yu, Zujun Fang, Jie Zheng, Ye Tian, Donghao Shang, Hanzhong Li, Zhongming Huang, Liqun Zhou, Yunxiang Xiao, Yaoguang Zhang, Jianlong Wang, Xiaodong Zhang, Peng Zhang, Dongwen Wang, Xuhui Zhang, Keji Xie, Bin Wang, Lulin Ma, Xiaojun Tian, Lijun Chen, Jinkai Dong

Connect to this object online.